5470-93-9

4,5,6-trichloro-N-methyl-N-phenylpyrimidin-2-amine

2-Pyrrolidinone, 3-acetyl-4-ethenyl-1-[(1R)-1-phenylethyl]-, (3R,4S)-

4-Morpholineethanol,2-[[[4-[(3,4-dichlorophenyl)amino]-6-methoxy-7-quinazolinyl]oxy]methyl]-

4-Quinazolinamine,N-(3,4-dichlorophenyl)-6-methoxy-7-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methoxy]-

Benzofuran, 7-chloro-5-fluoro-4-isothiocyanato-2-methyl-

2,4,6-Cycloheptatrien-1-one, 2-hydroxy-7-methyl-4-(1-methylethyl)-

1-(3,6-dioxo-2,5-diphenylcyclohexa-1,4-dien-1-yl)triaza-1,2-dien-2-ium

Decanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-5-hydroxy-,ethyl ester, (3R,5R)-rel-

Vasopressinase

4-Quinazolinamine,7-[(4-butylhexahydro-1,4-oxazepin-2-yl)methoxy]-N-(3,4-dichlorophenyl)-6-methoxy-

4-Quinazolinamine,N-(3,4-dichlorophenyl)-6-[[hexahydro-4-(2-methylpropyl)-1,4-oxazepin-2-yl]methoxy]-7-methoxy-

Morpholine,2-[[[4-[(3,4-dichlorophenyl)amino]-6-methoxy-7-quinazolinyl]oxy]methyl]-4-(methylsulfonyl)-

Dodecanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-5-hydroxy-,ethyl ester, (3R,5R)-rel-

1,3,2-Benzodioxaphosphole,2,2-dichloro-2-[[1-(ethylthio)-2-methyl-1-propenyl]thio]-2,2-dihydro-

Formamide, N-[1-methyl-2-(methylthio)ethenyl]-N-(phenylmethyl)-, (Z)-

Isoquinolinium, 3,4-dihydro-6,7-dimethoxy-, 2-methoxy-2-oxoethylide

Dodecanoic acid, 5-hydroxy-3-oxo-, ethyl ester

4-Quinazolinamine,N-(3,4-dichlorophenyl)-6-methoxy-7-(4-pyridinylmethoxy)-

Benzoic acid, 2,4,6-trinitro-, 2-(2,4,6-trinitrobenzoyl)hydrazide

Formamide, N-methyl-N-[1-methyl-2-(methylthio)ethenyl]-, (E)-

Benzoic acid, 3,5-dichloro-4-(trimethylsilyl)-

D-myo-Inositol, 3-(2S)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 1,5,6-tris(dihydrogen phosphate)

Morpholine,2-[[[4-[(3,4-dichlorophenyl)amino]-6-methoxy-7-quinazolinyl]oxy]methyl]-4-(4-methyl-1-oxopentyl)-

Hexanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-5-hydroxy-,ethyl ester, (3R,5S)-rel-

4-Quinazolinamine,N-(4-chloro-3-methylphenyl)-6-methoxy-7-[(4-methyl-2-morpholinyl)methoxy]-

benzylbis(2-hydroxypropyl)octadecadienylammonium chloride

Stannane, bis[2,6-bis(trifluoromethyl)phenyl]dichloro-

Benzamide,N-ethyl-3-methyl-N-(1-methylethyl)-5-[(2S)-2-(4-pyridinylamino)propoxy]-

3-Butenylium, 1-(methoxycarbonyl)-

1,4-Benzodioxin-2-methanol, 2,3-dihydro-, methanesulfonate, (2R)-

4-Morpholinecarboxylic acid,2-[2-[[4-[(3,4-dichlorophenyl)amino]-6-methoxy-7-quinazolinyl]oxy]ethyl]-5,5-dimethyl-, 1,1-dimethylethyl ester

2-Hexenoic acid, 5-hydroxy-3-[(phenylmethyl)amino]-, ethyl ester

3H-Pyrrolizine-2-carboxamide, 3-imino-5-methyl-1-(methylthio)-

Ethanol, 2-[2-[[6-[4-[(1E)-(4-butylphenyl)azo]phenoxy]hexyl]oxy]ethoxy]-

Imidazo[1,2-b]isoquinolin-10-ol,5-(4-chlorophenyl)-2,3,5,10-tetrahydro-10-phenyl-, (5R,10R)-rel-

1H-Azepine-1-carboxylic acid, 3-azidohexahydro-4-(phenylmethoxy)-,1,1-dimethylethyl ester, (3S,4S)-

Propanoic acid,3,3'-([2,2'-bipyridine]-6,6'-diyldiimino)bis[2,2-dimethyl-3-oxo-, diethylester

5470-93-9 msds

CAS No 5470-93-9 supplier

CASNo 5470-93-9 distributor

CAS # 5470-93-9 manufacturer

CAS Number 5470-93-9 safety

CAS RN 5470-93-9 wholesale

2026-10-13 Find 4,5,6-trichloro-N-methyl-N-phenylpyrimidin-2-amine,CAS No.5470-93-9,Formula:C11H8Cl3N3 in OrgMetal